Peptides Explained

John Garrett

Peptides Explained breaks down the most talked-about peptides and GLP-1 medications in health, fitness, and longevity — including semaglutide, tirzepatide, BPC-157, TB-500, and more. Hosted by Registered Nurse John Garrett, this podcast explains how these compounds work, why they're popular, what the research shows, and the real risks and side effects — all in plain language. No bro science. No hype. Just clear, foundational education. For informational purposes only. Not medical advice. For Research Peptides; Offlinepeptides.com/ref/johngarrett/ https://www.skool.com/peptides-explained-15

  1. 1 дн. тому ·  Додатково

    You Might Also Like: The Oprah Podcast

    Introducing Oprah Celebrates 40 Years of The Oprah Winfrey Show from The Oprah Podcast. Follow the show: The Oprah Podcast Today—September 8, 1986—marks the 40th anniversary of one of the most momentous days in Oprah's life and career. Forty years ago today the very first nationally syndicated episode of The Oprah Winfrey Show aired launching what would become a 25 year cultural phenomenon and pioneering television. In this special anniversary episode Oprah reflects on her extraordinary journey—from her early days as a news anchor in Nashville and Baltimore to her first audition tape and the lessons she learned hosting AM Chicago, the show that brought her to the Windy City. She also reveals the enduring early lessons that shaped her life's purpose and continue to guide her work today as well as how she lives each day in gratitude for what she considers a God-given opportunity. 00:00:00 Oprah on the beginning of The Oprah Winfrey Show 00:04:00 Oprah and Barbara Walters 00:09:00 Oprah’s audition and Dennis Swanson 00:18:30 - Oprah’s journal entry before her first national show 00:20:00 - Oprah's first show 00:30:00 - Oprah’s last show 00:35:50 - Don Johnson’s surprise Follow Oprah Winfrey on Social: https://www.instagram.com/oprahpodcast/ https://www.facebook.com/oprahwinfrey/ Listen to the full podcast: https://open.spotify.com/show/0tEVrfNp92a7lbjDe6GMLI https://podcasts.apple.com/us/podcast/the-oprah-podcast/id1782960381 DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to team@podroll.fm.

    You Might Also Like: The Oprah Podcast

  2. 6 дн. тому

    Thymalin vs Thymogen: Can Thymus Peptides Reverse Immune Aging?

    Can a peptide reverse age-related immune decline? Thymalin and Thymogen are often discussed together, but one is a complex calf-thymus extract and the other is the defined dipeptide Glu-Trp. John Garrett explains thymic involution, T-cell biology, proposed mechanisms, the Russian clinical history, limitations of the human evidence, safety, and U.S. regulatory status. The science is interesting. The "immune rejuvenation" and life-extension claims remain unproven. Educational only. Not medical advice.

  3. 31 серп.

    What Is Pinealon? Brain Aging, Neuroprotection, and the Evidence

    Check out The Peptide App here: thepeptide.app/explained What is Pinealon, and does this three-amino-acid peptide really protect the aging brain? Pinealon—also called EDR or Glu-Asp-Arg—is a synthetic tripeptide associated with the Khavinson bioregulator research program. It is discussed for memory, neuroprotection, oxidative stress, brain aging, and even Alzheimer's disease, but the evidence is much more complicated than the marketing language suggests. John Garrett, examines Pinealon's proposed mechanism, cell and animal research, a newer induced-neuron study, and the PubMed-indexed human reports that are often overlooked. The episode also explains why Pinealon is different from Epitalon, where the human evidence is weak, what remains unknown about brain exposure and long-term safety, and why a plausible mechanism is not the same thing as an established cognitive therapy. Educational content only. Not medical advice.

  4. 30 серп.

    Khavinson Peptide Bioregulators: What Do They Actually Do?

    What are Khavinson peptide bioregulators, and what do they actually do? John Garrett examines the Russian research tradition behind organ-derived peptide complexes and synthetic ultrashort peptides. This episode explains the proposed gene-expression mechanism, the claim of tissue specificity, common examples such as Thymalin and Epitalon, the limitations of the human evidence, oral absorption questions, product-quality concerns, safety, and U.S. regulatory status. The science is more interesting than a simple dismissal—but less proven than organ-rejuvenation marketing suggests. This episode is educational and is not medical advice.

  5. 30 серп.

    Did Your GLP-1 Stop Working? Appetite, Receptors and Weight-Loss Plateaus

    Does a weight-loss plateau mean your GLP-1 receptors have become desensitized? John separates cellular receptor biology from whole-body weight regulation and compares semaglutide, tirzepatide, and investigational retatrutide. We examine appetite suppression, food noise, gastric-emptying tachyphylaxis, metabolic adaptation, switching therapies, and what the clinical evidence can—and cannot—tell us. A plateau is real. "Receptor burnout" is a much bigger claim. Educational only; not medical advice.

  6. 20 серп.

    Should You Be Using Peptides? The Honest Answer

    Visit Peptide-Solutions.info for more info Check out App.PeptidesExplained.info Should you be using peptides? The honest answer is that not everyone should. Peptides are not a nutritional requirement, a shortcut to better health, or something you need simply because they are trending. But some people do have a defined problem—such as obesity, metabolic disease, an injury, loss of function, a diagnosed hormone-related condition, or another health issue—for which a peptide-based medication or investigational compound may be relevant. In this episode, John Garrett, explains how to decide whether a peptide belongs in the conversation. You will learn how to start with the problem rather than the product, compare FDA-approved, off-label, compounded, experimental, and research-use categories, evaluate human versus animal versus anecdotal evidence, identify better-established alternatives, and build a plan for monitoring and stopping. This episode also points viewers to "The 11 Peptides I Find Most Compelling" and the individual Peptides Explained deep dives for compound-specific education. This content is educational only and is not medical advice. Speak with a qualified healthcare professional before starting, stopping, or changing any therapy.

    Should You Be Using Peptides? The Honest Answer

  7. 18 серп.

    ARA-290: Can It Repair Small Nerve Fibers?

    ARA-290, also called cibinetide, is an investigational 11-amino-acid peptide designed from erythropoietin biology to activate tissue-protective signaling without stimulating red-blood-cell production. In this episode, John Garrett, RN, breaks down the innate repair receptor, why ARA-290 has been studied in small-fiber neuropathy, what randomized human trials in sarcoidosis and type 2 diabetes actually found, and why objective nerve-fiber signals are interesting—but not the same thing as an approved therapy. You'll learn: • What ARA-290/cibinetide is • How it differs from full-length erythropoietin • What the innate repair receptor is • Why researchers studied corneal nerve fibers • What the 22-patient pilot trial showed • What the 64-patient phase 2b trial showed • Why pain and nerve-fiber endpoints did not tell exactly the same story • What is known—and not known—about safety • Why online ARA-290 products should not be assumed equivalent to trial material Explore the Peptides Explained app: app.peptidesexplained.info Learn more through Peptide Solutions: peptide-solutions.info Educational content only. ARA-290 is investigational and is not an FDA-approved treatment for neuropathy or any other clinical indication.

    ARA-290: Can It Repair Small Nerve Fibers?

  8. 12 серп.

    Lipo-C Injections: What Do They Actually Do?

    Check out Peptide.Solutions.info/Pathways and submit a request to see what companies I have partnered with to get products. Lipo-C injections are often marketed for fat burning, energy, liver support, or breaking a weight-loss plateau. But "Lipo-C" is not one standardized formula—and real metabolic biology is not the same thing as proven fat loss. In this episode, John Garrett, RN, breaks down the ingredients commonly found in Lipo-C blends, including L-carnitine, choline, methionine, inositol, and B vitamins. We examine what each ingredient actually does, what human studies of L-carnitine suggest, why that evidence cannot automatically be applied to a compounded injection, and the questions to ask before paying for one. You'll learn: • Why two products called Lipo-C may be completely different • How carnitine participates in mitochondrial fatty-acid oxidation • What "lipotropic" does—and does not—mean • Whether Lipo-C is FDA approved • What people report versus what trials establish • Risks, limitations, and when provider involvement matters Explore the Peptides Explained app: app.peptidesexplained.info Learn more through Peptide Solutions: peptide-solutions.info Educational content only. This is not medical advice or a recommendation to use an injectable product.

    Lipo-C Injections: What Do They Actually Do?
Переглянути всі (47)

Опис

Peptides Explained breaks down the most talked-about peptides and GLP-1 medications in health, fitness, and longevity — including semaglutide, tirzepatide, BPC-157, TB-500, and more. Hosted by Registered Nurse John Garrett, this podcast explains how these compounds work, why they're popular, what the research shows, and the real risks and side effects — all in plain language. No bro science. No hype. Just clear, foundational education. For informational purposes only. Not medical advice. For Research Peptides; Offlinepeptides.com/ref/johngarrett/ https://www.skool.com/peptides-explained-15

Інформація

  • Автор
    John Garrett
  • Роки діяльності
    2026
  • Епізоди
    47
  • Категорія
    Не відверті
  • Авторське право
    © 2026
  • Вебсайт шоу
    Peptides Explained

Теж може цікавити